*Press releases are taken from the company websites.
*Titles may be translated independently.
*Please be aware that, since data is collected automatically, there is a possibility of omissions occurring.
*We would like to kindly inform you that we do not collect all press releases from companies.
| Ticker Code | Date | Title | Link |
|---|---|---|---|
| TSE:2269 | 4/3/2025 | A new product from ZABAS Drink Type has been released that contains "high-purity whey protein"!Contains 20g of protein, it is clear and tastes like a sports drink, and is "(Zabas) WHEY PROTEIN Muscat Flavor" - Recommended for those who are working hard to | https://www.meiji.co.jp/corporate/pressrelease/2025/04_03/ |
| JNJ | 4/3/2025 | Johnson & JohnsonGlobal Survey Reveals Confidence in AI and Medical Technology to Address Personalized Needs of the Aging Population and Alleviate Burnout Among Healthcare Professionals | https://www.jnj.com/media-center/press-releases/johnson-johnson-global-survey-reveals-confidence-in-ai-and-medical-technology-to-address-personalized-needs-of-the-aging-population-and-alleviate-burnout-among-healthcare-professionals |
| NVO | 4/3/2025 | Novo Nordisk announces changes in Executive Management | https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=915969 |
| NVS | 4/3/2025 | Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN) | https://www.novartis.com/news/media-releases/novartis-receives-fda-accelerated-approval-vanrafia-atrasentan-first-and-only-selective-endothelin-receptor-antagonist-proteinuria-reduction-primary-iga-nephropathy-igan |
| TSE:2269 | 4/2/2025 | Meiji Marugoto Oats, which contains the water-soluble dietary fiber "β-glucan," which is expected to be useful for a variety of health issues, has now released a new coffee flavor that goes well with oat milk!"Meiji Marugoto Oats Oats Milk Coffee" New Rel | https://www.meiji.co.jp/corporate/pressrelease/2025/04_02/ |
| TSE:4503 | 4/2/2025 | Astellas Pharmaceutical and Cancer Research Association, a public interest incorporated foundation Strategic alliances in translational research and clinical cancer research | https://www.astellas.com/jp/news/29801 |
| TSE:4507 | 4/2/2025 | Regarding the conclusion of a license agreement between Link in Australia and New Zealand for Cefiderokol, a drug for treating Gram-negative bacterial infections. | https://www.shionogi.com/jp/ja/news/2025/04/20250402.html |
| BIIB | 4/2/2025 | Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease | https://investors.biogen.com/news-releases/news-release-details/biogens-investigational-tau-targeting-therapy-biib080-receives |
| JNJ | 4/2/2025 | Johnson & JohnsonCloses Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership | https://www.jnj.com/media-center/press-releases/johnson-johnson-closes-landmark-intra-cellular-therapies-acquisition-to-solidify-neuroscience-leadership |
| TSE:2269 | 4/1/2025 | Delicious and easy to drink!New brand of containers with a new capacity of 700ml caps has been released: "Meiji Milk Healthy Bottle Farm Drip," "Meiji Milk Healthy Bottle Ca Iron + Dietary Fiber Delivery to Your Body," "Meiji Milk Healthy Bottle Lactic Ac | https://www.meiji.co.jp/corporate/pressrelease/2025/04_04/ |
| TSE:2269 | 4/1/2025 | Last time, approximately 2 million units sold!Popular flavors with sweet and sour tastes are now available for a limited time for the first time in two years "Fruit Juice Gummy Dark Cherry Mix" re-release on April 8th / nationwide | https://www.meiji.co.jp/corporate/pressrelease/2025/04_01/ |
| TSE:4506 | 4/1/2025 | Notice of the decision of the 2025 grant recipients, research reward recipients and research achievement award recipients, Research Achievement Award recipients, Public Interest Incorporated Foundation, Public Interest Incorporated Foundation | https://www.sumitomo-pharma.co.jp/news/assets/pdf/ne20250401.1.pdf |
| TSE:4507 | 4/1/2025 | COVID-19 Treatment drug Encitrelvir Fumaric acid Initiating a rolling submission to the FDA in preventing COVID-19 | https://www.shionogi.com/jp/ja/news/2025/04/202504010.html |
| TSE:4516 | 4/1/2025 | Regarding the company's induction ceremony "Message (Summary)" | https://www.nippon-shinyaku.co.jp/news/news.php?id=3341 |
| TSE:4521 | 4/1/2025 | Notice regarding the status of acquisition of treasury stock | https://ssl4.eir-parts.net/doc/4521/tdnet/2588585/00.pdf |